Back to Search
SCOTT REINES, MD, PHD
MD, PHD
Specialist
NPI: 1578804985Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD022925E(PA)
Research & Publications (12)
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study.
PMID 14718699·Neurology·2004
3-trial
Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.
PMID 19001248·Neurology·2008
4-observational
Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.
PMID 16492236·Headache·2006
4-observational
Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder.
PMID 16248986·Biol Psychiatry·2006
3-trial
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.
PMID 15742005·Neuropsychopharmacology·2005
3-trial
Look-alike, sound-alike drug errors with Reminyl and Amaryl.
PMID 15658069·Am J Health Syst Pharm·2005
4-observational
Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
PMID 15186302·Headache·2004
3-trial
Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine.
PMID 15136680·Neurology·2004
3-trial
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant.
PMID 15121485·Biol Psychiatry·2004
3-trial
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression.
PMID 14666114·Neuropsychopharmacology·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11 W BRIDLEWOOD DR
NEW HOPE, PA 18938 - Phone
- (215) 850-6895
Quick Facts
- NPI
- 1578804985
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 12
Are you this provider?
Claim Your Profile